131 -2 (40) 2022 — Yarmukhamedova N. A., Dzhumaeva N. S., — POST-COVID SYNDROME IN NEW CORONAVIRUS INFECTION

POST-COVID SYNDROME IN NEW CORONAVIRUS INFECTION

Yarmukhamedova N. A., Samarkand State Medical Institute,

Dzhumaeva N, S., Samarkand State Medical Institute,

Voseeva D. Kh,, Samarkand State Medical Institute,

Badalova R. G. Chief infectious disease specialist of the Central Multidisciplinary Polyclinic of the Samarkand City Medical Association

Resume

The COVID-19 epidemic has gradually passed from an acute to a protracted form, and by the second year of the pandemic, a “post-COVID syndrome” is being recorded. Completion of the acute phase of coronavirus infection has a different duration. This is shown by dynamic observations of millions of patients who have been ill over the past 2 years. The article discusses the clinical signs of post-COVID syndrome observed in subacute and chronic forms of COVID-19 disease. In the post-COVID period, the consequences of the COVID-19 disease and the causes of their occurrence are considered. In a third of patients, the acute inflammatory period of the disease can pass without any consequences. In the severe course of the disease, most patients experience various clinical signs and residual effects. Often these residual effects are proportional to the severity of the disease, in some cases the outcome and residual effects do not depend on the period of acute inflammation and the severity of the disease.

Key words: COVID-19, post-covid syndrome, protracted form, residual effects.

First page

657

Last page

661

For citation: Yarmukhamedova N. A., Dzhumaeva N, S., Voseeva D. Kh,, Badalova R. G. POST-COVID SYNDROME IN NEW CORONAVIRUS INFECTION //New Day in Medicine 2(40)2022 657-661 https://clck.ru/ehVyY

LIST OF REFERENCES:

  1. Узакова Г.З., Ярмухамедова Н.А., Джумаева Н.С. “Болаларда коронавирус инфекцияси кечишининг узига хос хусусиятлари”. //Журнал гепато-гастроэнтерологических исследований (2021). Инфекционные болезни − актуальные вопросы, достижения и инновационные подходы в охране здоровья населения. II – том. С-126-129.
  2. Джумаева Н.С., Ярмухамедова Н.А., Узакова Г.З. “Амалиётдан бир ҳолат Сovid-19 касаллиги ҳамроҳ касалликлар билан кечиш хусусиятлари”. //Журнал гепато-гастроэнтерологических исследований (2021). Инфекционные болезни − актуальные вопросы, достижения и инновационные подходы в охране здоровья населения. I- том. С-47-50.
  3. Шодиева Д.А., Ташпулатов Ш.А., Джумаева Н.С.  “Внешнее дыхание  при ботулизме у детей в зависимости от степени тяжести основного процесса” //Журнал «Вопросы науки и образования» №6 (131), 2021  35-43.
  4. Шодиева Д.А., Ташпулатов Ш.А. “Болаларда ботулизм касаллигининг оғирлик даражасига боғлиқ ташқи нафас тизими томонидан  кузатиладиган ўзгаришлар” ПБИМ 2021. №5 (130)  151-154.
  5. Wuhan Municipal Health Commission briefi ng on the pneumonia epidemic situation. 31 December 2019 (in Mandarin). Pneumonia of unknown cause – China. Disease outbreak news. 5 January 2020. WHO.
  6. Hu B., Guo H., Zhou P., Shi Z.-L. Characteristics of SARS-CoV-2 and COVID-19 // Nat. Rev. Microbiol. 2021. Vol. 19. Р. 141-154.
  7. Shang J. et al. Structural basis of receptor recognition by SARS-CoV-2 // Nature. 2020. Vol. 581. Р. 221-224.
  8. Wrobel A.G. et al. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects // Nat.Struct.  Mol. Biol. 2020. Vol. 27. Р. 763-767.
  9. Needham D.M. et al. Physical and cognitive performance of patients with acute lung injury 1 year after initial trophic versus full enteral feeding.  EDEN trial follow-up // Am. J. Respir. Crit. Care Med. 2013. Vol. 188. Р. 567-576.
  10. Pandharipande P.P. et al. Long-term cognitive impairment after critical illness // N. Engl. J. Med. 2013. Vol. 369. Р. 1306-1316.
  11. Inoue S. et al. Post-intensive care syndrome: its pathophysiology, prevention, and future directions // Acute Med. Surg. 2019. Vol. 6. Р. 233-246.
  12. Oblokulov, A.R., Niyozov, G.E. Clinical and epidemiological characteristics of patients with COVID-19 (2020) //International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.
  13. Oblokulov, A. R., Husenova, Z. Z., & Ergashev, M. M. (2021). Procalcitonin as an indicator of antibacterial therapy in covid-19. //Annals of the Romanian Society for Cell Biology, 5220-5224.
  14. Elmurodova A. A. (2022) “Specific Features of the Hemostatic System in Covid-19”. CENTRAL ASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES 3, 82-85.

file

download